A Prospective Trial of Infliximab Therapy for Refractory Uveitis
Open Access
- 1 July 2005
- journal article
- clinical trial
- Published by American Medical Association (AMA) in American Journal of Ophthalmology
- Vol. 123 (7), 903-912
- https://doi.org/10.1001/archopht.123.7.903
Abstract
Research from JAMA Ophthalmology — A Prospective Trial of Infliximab Therapy for Refractory Uveitis — Preliminary Safety and Efficacy OutcomesKeywords
This publication has 25 references indexed in Scilit:
- A randomized, placebo‐controlled, double‐masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritisArthritis Care & Research, 2005
- Infliximab Maintenance Therapy for Fistulizing Crohn's DiseaseNew England Journal of Medicine, 2004
- Anterior uveitis: current concepts of pathogenesis and interactions with the spondyloarthropathiesCurrent Opinion in Rheumatology, 2002
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentNew England Journal of Medicine, 2001
- New treatment options in spondyloarthropathies: increasing evidence for significant efficacy of anti–tumor necrosis factor therapyCurrent Opinion in Rheumatology, 2001
- Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panelAmerican Journal of Ophthalmology, 2000
- Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: A phase I/II clinical trialProceedings of the National Academy of Sciences of the United States of America, 1999
- Prognosticators for Visual Outcome in Sarcoid UveitisOphthalmology, 1996
- The natural history of uveitisInternational Ophthalmology, 1990
- International Uveitis Study Group Recommendations for the Evaluation of Intraocular Inflammatory DiseaseAmerican Journal of Ophthalmology, 1987